Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 7NIH 1NETWORK 1INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 3Thoracic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Melanoma 1

Interventions

Interferon-alpha 6Radiosurgery 4Dacarbazine 4encorafenib 3binimetinib 3aldesleukin 3Watchful Waiting 3Radiotherapy 3Methotrexate 3Immunohistochemistry 3Gene Expression Profiling 3Filgrastim 3Etoposide 3Cyclophosphamide 3Cisplatin 3X-Rays 2Vincristine 2Vinblastine 2Temozolomide 2Specimen Handling 2Polymerase Chain Reaction 2Observation 2Nivolumab 2Ipilimumab 2Introns 2Interferon alpha-2 2Immunologic Techniques 2Flow Cytometry 2Carboplatin 2trametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Immunoenzyme Techniques × Dermatologic × Clear all
NCT00897520 2017-05-19

Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy

Eastern Cooperative Oncology Group

Completed
40 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡